ATE366810T1 - Menschliche p51-gene und deren genprodukte - Google Patents

Menschliche p51-gene und deren genprodukte

Info

Publication number: ATE366810T1
Authority: AT; Austria
Prior art keywords: genes; human; gene products; protein; recombinant
Prior art date: 1998-03-27

Application number

AT99910698T

Other languages

English (en)

Inventor

Yoji Ikawa

Shuntaro Ikawa

Masuo Obinata

Original Assignee

Otsuka Pharma Co Ltd

Yoji Ikawa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-27

Filing date

1999-03-24

Publication date

2007-08-15

1999-03-24 Application filed by Otsuka Pharma Co Ltd, Yoji Ikawa filed Critical Otsuka Pharma Co Ltd

2007-08-15 Application granted granted Critical

2007-08-15 Publication of ATE366810T1 publication Critical patent/ATE366810T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AT99910698T 1998-03-27 1999-03-24 Menschliche p51-gene und deren genprodukte ATE366810T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP10046798		1998-03-27

Publications (1)

Publication Number	Publication Date
ATE366810T1 true ATE366810T1 (de)	2007-08-15

Family

ID=14274724

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT99910698T ATE366810T1 (de)	1998-03-27	1999-03-24	Menschliche p51-gene und deren genprodukte
AT07013470T ATE512162T1 (de)	1998-03-27	1999-03-24	Antikörper gegen das p51 protein

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT07013470T ATE512162T1 (de)	1998-03-27	1999-03-24	Antikörper gegen das p51 protein

Country Status (12)

Country	Link
US (4)	US7132276B1 (de)
EP (2)	EP1847607B1 (de)
JP (1)	JP4336926B2 (de)
CN (1)	CN100340665C (de)
AT (2)	ATE366810T1 (de)
CA (1)	CA2324649C (de)
CY (1)	CY1111763T1 (de)
DE (1)	DE69936513D1 (de)
DK (1)	DK1847607T3 (de)
ES (1)	ES2366234T3 (de)
PT (1)	PT1847607E (de)
WO (1)	WO1999050412A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL147256A0 (en)	1999-06-29	2002-08-14	Nippon Kayaku Kk	Gene encoding promoter region of tumor suppressor gene p51 and use thereof
WO2005086068A2 (en) *	2004-02-27	2005-09-15	Aureon Laboratories, Inc.	Methods and systems for predicting occurrence of an event
CN102181571A (zh) *	2011-05-20	2011-09-14	清华大学	辅助鉴定猪遗传稳定性相关基因的专用引物及其应用
CN102181570A (zh) *	2011-05-20	2011-09-14	清华大学	辅助鉴定鼠遗传稳定性相关基因的专用引物及其应用
CN104212879B (zh) *	2013-06-05	2016-09-21	上海派森诺生物科技股份有限公司	一种基于磁珠富集法高通量开发基因组ssr标记的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2744455B1 (fr) *	1996-02-02	1998-04-24	Sanofi Sa	Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
AU7478098A (en)	1997-05-12	1998-12-08	Dana-Farber Cancer Institute	Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
US7294459B1 (en) *	1997-10-15	2007-11-13	President And Fellows Of Harvard College	Cell regulatory genes, encoded products, and uses related thereto
AU1099699A (en) *	1997-10-15	1999-05-03	President And Fellows Of Harvard College	Cell regulatory genes, encoded products, and uses related thereto
ATE345387T1 (de)	1998-03-18	2006-12-15	Corixa Corp	Verbindungen und verfahren für therapie und diagnose von lungenkrebs
US6476206B1 (en)	1998-03-27	2002-11-05	The Johns Hopkins University	p40 protein acts as an oncogene
DE19822985C1 (de)	1998-05-25	2000-01-13	Fraunhofer Ges Forschung	Tumorsuppressorgene der p53-Familie

1999
- 1999-03-24 CA CA002324649A patent/CA2324649C/en not_active Expired - Lifetime
- 1999-03-24 WO PCT/JP1999/001512 patent/WO1999050412A1/ja not_active Ceased
- 1999-03-24 ES ES07013470T patent/ES2366234T3/es not_active Expired - Lifetime
- 1999-03-24 AT AT99910698T patent/ATE366810T1/de not_active IP Right Cessation
- 1999-03-24 DK DK07013470.5T patent/DK1847607T3/da active
- 1999-03-24 AT AT07013470T patent/ATE512162T1/de active
- 1999-03-24 EP EP07013470A patent/EP1847607B1/de not_active Expired - Lifetime
- 1999-03-24 EP EP99910698A patent/EP1065270B1/de not_active Expired - Lifetime
- 1999-03-24 PT PT07013470T patent/PT1847607E/pt unknown
- 1999-03-24 JP JP2000541300A patent/JP4336926B2/ja not_active Expired - Lifetime
- 1999-03-24 US US09/670,568 patent/US7132276B1/en not_active Expired - Lifetime
- 1999-03-24 CN CNB998045659A patent/CN100340665C/zh not_active Expired - Lifetime
- 1999-03-24 DE DE69936513T patent/DE69936513D1/de not_active Expired - Lifetime
2006
- 2006-01-27 US US11/340,715 patent/US7553933B2/en not_active Expired - Fee Related
2008
- 2008-07-08 US US12/169,213 patent/US7754857B2/en not_active Expired - Fee Related
2010
- 2010-05-24 US US12/786,018 patent/US7964367B2/en not_active Expired - Fee Related
2011
- 2011-08-22 CY CY20111100801T patent/CY1111763T1/el unknown

Also Published As

Publication number	Publication date
ATE512162T1 (de)	2011-06-15
CN1295615A (zh)	2001-05-16
EP1065270B1 (de)	2007-07-11
ES2366234T3 (es)	2011-10-18
CA2324649A1 (en)	1999-10-07
US7132276B1 (en)	2006-11-07
CA2324649C (en)	2007-05-15
US7754857B2 (en)	2010-07-13
EP1847607A1 (de)	2007-10-24
US7964367B2 (en)	2011-06-21
EP1065270A4 (de)	2004-12-29
DE69936513D1 (de)	2007-08-23
HK1034288A1 (en)	2001-10-19
JP4336926B2 (ja)	2009-09-30
DK1847607T3 (da)	2011-07-18
US7553933B2 (en)	2009-06-30
WO1999050412A1 (en)	1999-10-07
CY1111763T1 (el)	2015-10-07
EP1847607B1 (de)	2011-06-08
US20100285499A1 (en)	2010-11-11
PT1847607E (pt)	2011-08-25
CN100340665C (zh)	2007-10-03
EP1065270A1 (de)	2001-01-03
US20090142783A1 (en)	2009-06-04
US20060115852A1 (en)	2006-06-01

Similar Documents

Publication	Publication Date	Title
DE69634726D1 (de)	2005-06-16	Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
NZ504548A (en)	2003-06-30	Polypeptides and nucleic acids encoding human chordin
ATE382055T1 (de)	2008-01-15	Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
BR9507594A (pt)	1997-09-16	Processo para o tratamento de glomerulonefrite em um paciente necessitado deste tratamento artigo de fabricação anticorpo hibridoma 5g.1;1 molécula deácido nucleico proteina isolada polipeptideo isolado vetor de ácido nucleico célula hospedeira recombinante processo para produzir um polipeptideo de anticorpo c5 isolado anticorpo anti-c5 isolado processo para produzir uma proteina de anticorpo anti-c5 isolado molécula de ácido nucleico isolada processo para produzir um anticorpo anti-c5 anticorpo anti-c5 fragmento 5g46k fragmento 5g27k peptideo 5g325aa isolado peptideo 5g200aa isolado oligopeptideo isolado processo para induzir um animal a produzir um anti-c5 processo para identificar um anticorpo anti-c5 e processo para tratar um paciente necessitado de inibiçao complemetar
ATE339878T1 (de)	2003-12-15	Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
GB9722320D0 (en)	1997-12-17	Human cell cycle checkpoint proteins
ATE534742T1 (de)	2011-12-15	Polypeptide und nukleinsäuren von phorphorymonas gingivalis
CY1111763T1 (el)	2015-10-07	ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
WO2000040723A3 (en)	2000-11-02	Methods and products for delivering nucleic acids
NO980122L (no)	1998-03-05	Emaljematriksrelatert polypeptid
AU1444699A (en)	1999-07-05	Single-chain polypeptides comprising troponin i and troponin
DE60142356D1 (de)	2010-07-22	18480 humane proteinkinasemoleküle und ihre verwendungen
DE59108261D1 (de)	1996-11-14	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
NO874704L (no)	1987-11-11	Minaktivin fremstilt ved rekombinant dna-teknikk.
EP0723014A3 (de)	1998-03-04	cDNA des DOCK180 Gens und DOCK180 Protein
EP0723016A3 (de)	1997-08-20	Leukocyten-aktivierender Faktor
WO2002012475A3 (en)	2003-05-15	C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2003018806A1 (fr)	2003-03-06	Nouveau gene humain bmcc1
DE69932644D1 (de)	2006-09-14	Menschliches Protein mit in vitro antiproliferativer Aktivität.
WO2003099995A3 (en)	2004-03-18	Murine ortholog of the human disrupted-in-schizophrenia 1 gene
CO5070672A1 (es)	2001-08-28	Polipeptido de proteina c humana
AU2002352068A1 (en)	2003-03-03	2150, a human protein kinase family member and uses therefor
AU7871101A (en)	2002-02-25	Nucleic acids and proteins showing increased expression dose under salt stress
WO2003008621A3 (en)	2004-12-29	87144, human amino acid transporter family member and uses therefor
WO2002024913A3 (en)	2003-05-15	32612, a novel human peptide transporter and uses therefor

Legal Events

Date	Code	Title	Description
2008-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties